Gainers
- Akanda (NASDAQ:AKAN) shares increased by 64.1% to $42.65 during Thursday's regular session. The market value of their outstanding shares is at $13.8 million.
- Picard Medical (AMEX:PMI) shares moved upwards by 54.43% to $0.73. The market value of their outstanding shares is at $35.6 million.
- OSR Holdings (NASDAQ:OSRH) shares moved upwards by 51.43% to $0.7. The market value of their outstanding shares is at $11.8 million.
- NewcelX (NASDAQ:NCEL) stock increased by 31.57% to $4.5. The market value of their outstanding shares is at $17.2 million. As per the news, the FY earnings report came out today.
- NovoCure (NASDAQ:NVCR) stock moved upwards by 27.49% to $15.21. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today.
- Glaukos (NYSE:GKOS) stock moved upwards by 19.36% to $139.61. The company's market cap stands at $6.8 billion. As per the news, the Q1 earnings report came out yesterday.
Losers
- Option Care Health (NASDAQ:OPCH) stock fell 29.7% to $18.89 during Thursday's regular session. The market value of their outstanding shares is at $4.2 billion. As per the press release, Q1 earnings came out today.
- Enveric Biosciences (NASDAQ:ENVB) shares decreased by 25.97% to $3.82. The market value of their outstanding shares is at $10.2 million.
- Acadia Healthcare Co (NASDAQ:ACHC) stock declined by 15.72% to $23.82. The market value of their outstanding shares is at $2.6 billion. The company's, Q1 earnings came out yesterday.
- Waystar Holding (NASDAQ:WAY) shares declined by 14.96% to $21.49. The market value of their outstanding shares is at $4.8 billion. The company's, Q1 earnings came out yesterday.
- Atlantic International (NASDAQ:ATLN) shares decreased by 13.07% to $1.53. The market value of their outstanding shares is at $139.6 million.
- Design Therapeutics (NASDAQ:DSGN) shares decreased by 12.23% to $13.86. The company's market cap stands at $986.1 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment